| RS2153739384 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153741176 |
NRCAM
|
Health Risk |
Conflicting classifications of pathogenicity |
NRCAM-related disorder, NRCAM-related disorder |
| RS2153749469 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153749819 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS2153752710 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153755942 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153773364 |
KCNMA1
|
Health Risk |
Pathogenic |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Generalized epilepsy-paroxysmal dyskinesia syndrome |
| RS2153783491 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2153791497 |
CACNA1C
|
Health Risk |
Pathogenic |
— |
| RS2153792212 |
KCNMA1
|
Health Risk |
Likely pathogenic |
Liang-Wang syndrome, Liang-Wang syndrome |
| RS2153792334 |
KCNMA1
|
Health Risk |
Pathogenic |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Generalized epilepsy-paroxysmal dyskinesia syndrome |
| RS2153795389 |
NDUFS3
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2153806528 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153808479 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153808894 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153809530 |
SYNE1
|
Health Risk |
Pathogenic |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS2153811844 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2153825777 |
UNC80
|
Health Risk |
Pathogenic |
— |
| RS2153826963 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2153827732 |
UNC80
|
Health Risk |
Pathogenic |
— |
| RS2153828150 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2153828826 |
UNC80
|
Health Risk |
Pathogenic |
Hypotonia, infantile |
| RS2153829891 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2153831497 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2153835962 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2153836342 |
BRCA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2153836962 |
SYNE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2153837157 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2153864590 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2153871795 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2153875539 |
NEB
|
Health Risk |
Pathogenic |
— |
| RS2153875876 |
KCNMA1
|
Health Risk |
Pathogenic |
Liang-Wang syndrome, Liang-Wang syndrome |
| RS2153881466 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS2153889881 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS2153902749 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153902894 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153903111 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153903239 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153903290 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153903564 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153903589 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153903647 |
SYNE1
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2153903681 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153916116 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2153916214 |
MPL
|
Health Risk |
Pathogenic |
Essential thrombocythemia, Congenital amegakaryocytic thrombocytopenia |
| RS2153916273 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2153916450 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2153916495 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2153916498 |
MPL
|
Health Risk |
Pathogenic |
Essential thrombocythemia, Congenital amegakaryocytic thrombocytopenia |
| RS2153916885 |
MPL
|
Health Risk |
Likely pathogenic |
Essential thrombocythemia, Congenital amegakaryocytic thrombocytopenia |
| RS2153917033 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2153917100 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2153917236 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2153917276 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2153918495 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2153918515 |
MPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2153918730 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2153918764 |
MPL
|
Health Risk |
Pathogenic |
Essential thrombocythemia, Congenital amegakaryocytic thrombocytopenia |
| RS2153918774 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2153918792 |
MPL
|
Health Risk |
Pathogenic |
Essential thrombocythemia, Congenital amegakaryocytic thrombocytopenia |
| RS2153918800 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2153918831 |
MPL
|
Health Risk |
Pathogenic |
Essential thrombocythemia, Congenital amegakaryocytic thrombocytopenia |
| RS2153919240 |
MPL
|
Health Risk |
Pathogenic |
Essential thrombocythemia, Congenital amegakaryocytic thrombocytopenia |
| RS2153919318 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2153919319 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2153919390 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2153919403 |
MPL
|
Health Risk |
Pathogenic |
Essential thrombocythemia, Congenital amegakaryocytic thrombocytopenia |
| RS2153919438 |
MPL
|
Health Risk |
Pathogenic |
Essential thrombocythemia, Congenital amegakaryocytic thrombocytopenia |
| RS2153920030 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2153923212 |
ELOVL1
|
Health Risk |
Pathogenic |
Ichthyotic keratoderma, spasticity |
| RS2153923874 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153923895 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153923925 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153924098 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153924986 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153925061 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153925181 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153925252 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153930361 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS2153930733 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS2153930856 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153930968 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153931339 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153931607 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153932173 |
SZT2
|
Health Risk |
Likely pathogenic |
— |
| RS2153932502 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2153932585 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2153934176 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2153934979 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2153935278 |
SZT2
|
Health Risk |
Likely pathogenic |
— |
| RS2153935420 |
SZT2
|
Health Risk |
Likely pathogenic |
Seizure, Seizure |
| RS2153935570 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2153935815 |
SZT2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS2153935951 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2153936018 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2153936775 |
SZT2
|
Health Risk |
Likely pathogenic |
— |
| RS2153937126 |
SYNE1
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2153939368 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS2153940243 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153940505 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |